Caplacizumab

ATC B01AX07 · 6 markets · 6 records

Caplacizumab 6 markets · 6 records Forms

GB 1 records · 1 strengths

  • 10 mginjectionCablivi 10mg powder and solvent for solution for injection vials also in ES·FR

ES 1 records · 1 strengths

TW 1 records · 1 strengths

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名Cablivi 10 mg Powder and solvent for solution for injection ×2可利康凍晶注射劑10毫克 ×2

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
      With a brand name Con nombre comercial 有商品名 有商品名Cablivi ×2

      Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

      FR 1 records · 1 strengths

      • 10 mginjectionCABLIVI 10 mg, poudre et solvant pour solution injectable also in GB·ES
      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

      A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.